Through the power of synthetic biology and genetic code expansion we have developed a novel site-specific protein conjugation platform that allows precise control over conjugation site and number of conjugations on the protein of interest. Based on this platform we are developing a number of cutting-edge protein conjugates towards potential treatments for various indications.